Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.

Lawn SD, Bekker LG, Miller RF.

Lancet Infect Dis. 2005 Jun;5(6):361-73. Review.

PMID:
15919622
2.

Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.

de Boer MG, Kroon FP, Kauffmann RH, Vriesendorp R, Zwinderman K, van Dissel JT.

Neth J Med. 2003 Dec;61(12):408-12.

3.

Immune restoration disease: a consequence of dysregulated immune responses after HAART.

Stone SF, Price P, French MA.

Curr HIV Res. 2004 Jul;2(3):235-42. Review.

PMID:
15279587
4.

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease.

Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French MA, Price P.

AIDS. 2011 Jul 31;25(12):1455-60. doi: 10.1097/QAD.0b013e328348fb18.

PMID:
21610488
5.

Immune restoration disease after antiretroviral therapy.

French MA, Price P, Stone SF.

AIDS. 2004 Aug 20;18(12):1615-27. Review.

PMID:
15280772
6.

Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.

Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA.

J Clin Virol. 2001 Oct;22(3):279-87.

PMID:
11564593
7.

Mycobacterial immune restoration disease: one symphony, two or many?

Price P.

AIDS. 2012 Jan 2;26(1):119-20. doi: 10.1097/QAD.0b013e32834d4f97. No abstract available.

PMID:
21941164
8.
9.

Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease.

Olalla J, Pulido F, Rubio R, Costa MA, Monsalvo R, Palenque E, Costa JR, Del PA.

Int J Tuberc Lung Dis. 2002 Jan;6(1):71-5.

PMID:
11931404
10.

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, Price P, Flexman JP, Tay-Kearney ML.

HIV Med. 2000 Mar;1(2):107-15.

11.
12.

Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.

Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O'Shaughnessy M, Montaner J.

Clin Infect Dis. 2005 Nov 15;41(10):1483-97. Epub 2005 Oct 12.

PMID:
16231262
13.
14.

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

Jevtović DJ, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.

HIV Med. 2005 Mar;6(2):140-3.

15.

Leprosy occurring as immune reconstitution syndrome.

Deps PD, Lockwood DN.

Trans R Soc Trop Med Hyg. 2008 Oct;102(10):966-8. doi: 10.1016/j.trstmh.2008.06.003. Epub 2008 Jul 18. Review.

PMID:
18639911
17.

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.

Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2006 Jan;25(1):53-8.

18.

Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy.

Shor-Posner G, Miguez MJ, Pineda LM, Rodriguez A, Ruiz P, Castillo G, Burbano X, Lecusay R, Baum M.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):169-73.

PMID:
11832687
19.

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ.

AIDS. 2005 Mar 4;19(4):399-406.

PMID:
15750393
20.

Skin infections in HIV-infected individuals in the era of HAART.

Rodgers S, Leslie KS.

Curr Opin Infect Dis. 2011 Apr;24(2):124-9. doi: 10.1097/QCO.0b013e328342cb31. Review.

PMID:
21169832

Supplemental Content

Support Center